Panbela Therapeutics, Inc.

PBLA · OTC
Analyze with AI
9/30/2024
6/30/2024
3/31/2024
12/31/2023
Assets
Cash & Equivalents$142$59$262$2,578
Short-Term Investments$0$0$0$0
Receivables$332$320$313$183
Inventory$0$0$0$0
Other Curr. Assets$4,694$393$1,210$299
Total Curr. Assets$5,168$772$1,785$3,060
Property Plant & Equip (Net)$0$0$0$0
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$8,642$8,742$8,742
Total NC Assets$0$8,642$8,742$8,742
Other Assets$0$0$0$0
Total Assets$5,168$9,414$10,527$11,802
Liabilities
Payables$10,950$14,293$8,506$9,939
Short-Term Debt$3,200$1,000$1,000$1,000
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$5,992$1,495$1,013$1,379
Total Curr. Liab.$20,142$16,788$10,519$12,318
LT Debt$3,194$3,194$3,194$4,194
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$3,194$3,194$3,194$4,194
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$23,336$19,982$13,713$16,512
Equity
Pref Stock$0$0$0$0
Common Stock$5$5$5$0
Retained Earnings-$146,936-$139,757-$132,617-$125,497
AOCI$541$962$1,204$745
Other Equity$128,222$128,222$128,222$120,042
Total Equity-$18,168-$10,568-$3,186-$4,710
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$5,168$9,414$10,527$11,802
Net Debt$6,252$4,135$3,932$2,616